EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adropin inhibits cardiomyocyte apoptosis and attenuates myocardial fibrosis in rats with diabetic cardiomyopathy

Shuai Zhuang, Wei Ting, Zou Luwei, Zeng Gang, Liu Mao

Bali Medical Journal · 28.04.2026 · 15 (2) · 179-185

DOI: 10.15562/bmj.v15i2.5873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bali Medical Journal, online erschienen am 28.04.2026. Verfasst von Shuai Zhuang und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Myocardial apoptosis and fibrosis, which eventually result in heart failure, are the hallmarks of diabetic cardiomyopathy (DCM), a serious consequence of diabetes mellitus. A newly discovered peptide hormone called adropin has been linked to cardiovascular homeostasis and metabolic control. Its function in DCM is still not well known, though. The purpose of this study is to examine how Adropin affects myocardium fibrosis and apoptosis in a rat model of DCM.

Methods

Eight-week-old male Wistar rats were randomly assigned to four groups: normal control (CON), DCM model (DCM), adropin-treated (ADR), and perindopril-treated (PER). Streptozotocin was used to induce DCM. The rats were put to death after four weeks, and their hearts were removed. Masson's trichrome staining was used to measure myocardial fibrosis, while TUNEL staining was used to identify cardiomyocyte apoptosis. Western blot analysis was used to determine the expression levels of proteins linked to apoptosis.

Results

The DCM group showed more severe myocardial fibrosis and a significantly higher rate of cardiomyocyte apoptosis when compared to the CON group. All differences reached statistical significance (P < 0.05). In particular, Bax and cleaved caspase-3 expression levels were significantly higher (P < 0.05) while Bcl-2 protein expression was significantly lower (P < 0.05). On the other hand, there were statistically significant differences between the ADR and PER groups and the DCM group in terms of cardiomyocyte apoptosis and myocardial fibrosis. Additionally, Bax and cleaved caspase-3 expression levels were significantly lower (P < 0.05), whereas Bcl-2 expression was significantly higher (P = 0.001) and (P = 0.002).

Conclusion

In rats with diabetic cardiomyopathy, adropin can prevent cardiomyocyte death and enhance cardiac remodeling, indicating its potential as a therapeutic drug.

Zitieren

APA

Zhuang, S., Ting, W., Luwei, Z., Gang, Z., & Mao, L. (2026). Adropin inhibits cardiomyocyte apoptosis and attenuates myocardial fibrosis in rats with diabetic cardiomyopathy. Bali Medical Journal, 15(2), 179-185. https://doi.org/10.15562/bmj.v15i2.5873

Vancouver

Zhuang S, Ting W, Luwei Z, Gang Z, Mao L. Adropin inhibits cardiomyocyte apoptosis and attenuates myocardial fibrosis in rats with diabetic cardiomyopathy. Bali Medical Journal. 2026;15(2):179-185. doi:10.15562/bmj.v15i2.5873

BibTeX
@article{Zhuang2026,
  author = {Zhuang, Shuai and Ting, Wei and Luwei, Zou and Gang, Zeng and Mao, Liu},
  title = {Adropin inhibits cardiomyocyte apoptosis and attenuates myocardial fibrosis in rats with diabetic cardiomyopathy},
  journal = {Bali Medical Journal},
  year = {2026},
  volume = {15},
  number = {2},
  pages = {179--185},
  doi = {10.15562/bmj.v15i2.5873}
}
Kostenlos starten →